AAAAAA
Results:
1-13
|
Results: 13
Authors:
Fink, D
Schlagbauer-Wadl, H
Selzer, E
Lucas, T
Wolff, K
Pehamberger, H
Eichler, HG
Jansen, B
Citation: D. Fink et al., Elevated procaspase levels in human melanoma, MELANOMA RE, 11(4), 2001, pp. 385-393
Authors:
Hoeller, C
Jansen, B
Heere-Ress, E
Pustelnik, T
Mossbacher, U
Schlagbauer-Wadl, H
Wolff, K
Pehamberger, H
Citation: C. Hoeller et al., Perilesional injection cutaneous melanoma of r-GM-CSF in patients with metastases, J INVES DER, 117(2), 2001, pp. 371-374
Authors:
Kandioler-Eckersberger, D
Ludwig, C
Rudas, M
Kappel, S
Janschek, E
Wenzel, C
Schlagbauer-Wadl, H
Mittlbock, M
Gnant, M
Steger, G
Jakesz, R
Citation: D. Kandioler-eckersberger et al., TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients, CLIN CANC R, 6(1), 2000, pp. 50-56
Authors:
Halaschek-Wiener, J
Wacheck, V
Schlagbauer-Wadl, H
Wolff, K
Kloog, Y
Jansen, B
Citation: J. Halaschek-wiener et al., A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells, MOL MED, 6(8), 2000, pp. 693-704
Authors:
Selzer, E
Wacheck, V
Kodym, R
Schlagbauer-Wadl, H
Schlegel, W
Pehamberger, H
Jansen, B
Citation: E. Selzer et al., Erythropoietin receptor expression in human melanoma cells, MELANOMA RE, 10(5), 2000, pp. 421-426
Authors:
Jansen, B
Wacheck, V
Heere-Ress, E
Schlagbauer-Wadl, H
Hoeller, C
Lucas, T
Hoermann, M
Hollenstein, U
Wolff, K
Pehamberger, H
Citation: B. Jansen et al., Chemosensitisation of malignant melanoma by BCL2 antisense therapy, LANCET, 356(9243), 2000, pp. 1728-1733
Authors:
Jansen, B
Graselli, U
Dallinger, S
Kiss, B
Wacheck, V
Schlagbauer-Wadl, H
Assandri, A
Muller, M
Citation: B. Jansen et al., Pharmacokinetics and pharmacodynamics of the novel H-1-receptor antagonistemedastine in healthy volunteers, EUR J CL PH, 55(11-12), 2000, pp. 837-841
Authors:
Schlagbauer-Wadl, H
Klosner, G
Heere-Ress, E
Waltering, S
Moll, I
Wolff, K
Pehamberger, H
Jansen, B
Citation: H. Schlagbauer-wadl et al., Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice, J INVES DER, 114(4), 2000, pp. 725-730
Authors:
Jansen, B
Heere-Ress, E
Schlagbauer-Wadl, H
Halaschek-Wiener, J
Waltering, S
Moll, I
Pehamberger, H
Marciano, D
Kloog, Y
Wolff, K
Citation: B. Jansen et al., Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice, J MOL MED-J, 77(11), 1999, pp. 792-797
Authors:
Jansen, B
Schlagbauer-Wadl, H
Kahr, H
Heere-Ress, E
Mayer, BX
Eichler, HG
Pehamberger, H
Gana-Weisz, M
Ben-David, E
Kloog, Y
Wolff, K
Citation: B. Jansen et al., Novel Ras antagonist blocks human melanoma growth, P NAS US, 96(24), 1999, pp. 14019-14024
Authors:
Schlagbauer-Wadl, H
Griffioen, M
van Elsas, A
Schrier, PI
Pustelnik, T
Eichler, HG
Wolff, K
Pehamberger, H
Jansen, B
Citation: H. Schlagbauer-wadl et al., Influence of increased c-Myc expression on the growth characteristics of human melanoma, J INVES DER, 112(3), 1999, pp. 332-336
Authors:
Schlagbauer-Wadl, H
Jansen, B
Muller, M
Polterauer, P
Wolff, K
Eichler, HG
Pehamberger, H
Konak, E
Johnson, JP
Citation: H. Schlagbauer-wadl et al., Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice, INT J CANC, 81(6), 1999, pp. 951-955
Authors:
Smith-Jones, PM
Bischof, C
Leimer, M
Gludovacz, D
Angelberger, P
Pangerl, T
Peck-Radosavljevic, M
Hamilton, G
Kaserer, K
Kofler, A
Schlagbauer-Wadl, H
Traub, T
Virgolini, I
Citation: Pm. Smith-jones et al., DOTA-lanreotide: A novel somatostatin analog for tumor diagnosis and therapy, ENDOCRINOL, 140(11), 1999, pp. 5136-5148
Risultati:
1-13
|